Narayana Hrudayalaya Ltd.
Snapshot View

693.90 +12.55 ▲1.8%

16 August 2022, 04:01:00 PM
Volume: 20,464

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.narayanahealth.org
Market Cap 14,071.26 Cr.
Enterprise Value(EV) 14,263.10 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 18.41 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 37.39 Trailing Twelve Months Ending 2022-06
Industry PE 46.92 Trailing Twelve Months Ending 2022-06
Book Value / Share 78.11 Trailing Twelve Months Ending 2022-06
Price to Book Value 8.82 Calculated using Price: 688.55
Dividend Yield 0.15 Period Ending 2022-03
No. of Shares Subscribed 20.44 Cr. 204,360,804 Shares
FaceValue 10
Company Profile
The company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals. It has a network of multispecialty and superspeciality hospitals spread across multiple locations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.84%
1 Week
+5.34%
1 Month
+4.09%
3 Month
+2.44%
6 Month
+5.81%
1 Year
+40.11%
2 Year
+108.47%
5 Year
+131.49%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 6.27 0.88 5.19 9.96 5.67 5.87 11.08 -0.66 26.95
Return on Capital Employed (%) 10.21 6.36 9.37 14.77 9.25 9.46 13.80 1.84 27.28
Return on Assets (%) 3.34 0.47 2.91 5.68 2.68 2.39 4.44 -0.26 11.89

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 547 580 768 876 963 1,036 1,081 1,136 1,120 1,489
Non Curr. Liab. 214 261 258 365 361 981 1,041 1,151 944 860
Curr. Liab. 197 312 343 315 323 510 510 602 703 783
Minority Int. 5 3 1 0 0 0 0 1 1 1
Equity & Liab. 963 1,156 1,370 1,556 1,647 2,528 2,633 2,889 2,768 3,132
Non Curr. Assets 787 917 1,110 1,270 1,345 2,048 2,106 2,303 2,103 2,219
Curr. Assets 176 239 260 286 302 479 527 586 665 913
Misc. Exp. not W/O
Total Assets 963 1,156 1,370 1,556 1,647 2,528 2,633 2,889 2,768 3,132

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1,095 1,364 1,614 1,878 2,281 2,861 3,128 2,583 3,701 3,874
Other Income 22 8 16 23 19 19 28 27 35 37
Total Income 1,118 1,372 1,630 1,902 2,300 2,880 3,156 2,611 3,736 3,911
Total Expenditure -972 -1,238 -1,437 -1,649 -2,061 -2,566 -2,701 -2,394 -3,038 -3,163
PBIDT 145 133 193 252 239 314 455 217 698 748
Interest -31 -45 -33 -28 -55 -81 -94 -82 -76 -64
Depreciation -57 -68 -76 -80 -100 -137 -186 -184 -183 -186
Taxation -21 -15 -30 -52 -29 -34 -42 42 -88 -113
Exceptional Items -11 -1 1 -11
PAT 35 6 43 91 56 62 122 -7 351 384
Minority Interest 2 2 0 0 0 0 0 0 0 0
Share Associate -6 -25 -22 -8 -5 -2 -3 -7 -9 -7
Other Related Items
Consolidated Net Profit 32 -17 21 83 51 59 119 -14 342 376
Adjusted EPS 2 -1 1 4 3 3 6 -1 17 18

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 45 110 77 174 219 182 279 443 304 485
Cash Fr. Inv. -147 -168 -222 -150 -146 -534 -161 -189 -113 -267
Cash Fr. Finan. 108 57 140 18 -45 315 -27 -247 -194 -159
Net Change 6 -1 -5 42 28 -36 90 8 -2 59
Cash & Cash Eqvt 24 24 21 -11 17 -5 84 92 90 149

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85
Public 36.15 36.15 36.15 36.15 36.15 36.15 36.15 36.15 36.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Audio/ Video Recording Of Earnings Call For The First Quarter Ended 30Th June 2022
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) please be informed that the Earnings Call of the Company for the quarter ended 30th June 2022 was held on 11th August 2022 and the Audio/ Video Recording w.r.t. the Earnings Call has been uploaded on the same day and is available on the website of the Company at https://www.narayanahealth.org/stakeholder-relations/earning-call-transcripts.
Wed, 10 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Enclosed the copy of the advertisement published on Wednesday 10th August 2022 in English and Regional Newspaper (Kannada) for Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June 2022
Wed, 10 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Enclosed herewith copies of the newspaper advertisements published on Tuesday 9th August 2022 in English and Regional Newspaper (Kannada) giving Notice of the 22nd Annual General Meeting of the Company to be held on Tuesday August 30 2022 at 11:30 A.M (IST) through Video Conferencing/Other Audio Visual Means

Technical Scans View Details >>

Fri, 12 Aug 2022
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 1 Year High Increase 1 Year
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,569.90 +2.0%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Narayana Hrudayalaya Ltd.

Can I Buy Narayana Hrudayalay Shares now?

What is the Share Price of Narayana Hrudayalay?

What is the Relative Strength Index (RSI) Value of Narayana Hrudayalay?

What is the Market Capital (MCAP) of Narayana Hrudayalay?

What are the key metrics to analyse Narayana Hrudayalay?

What is the Price Performance of Narayana Hrudayalay?